SNY
Sanofi · Healthcare · Drug Manufacturers - General
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 278.78K | $11.31M | n/a | n/a |
| Q2 2026 | 109 | +6 | 144.55M | $6.22B | +8 | −4 |
| Q1 2026 | 107 | -7 | 161.36M | $7.80B | +3 | −10 |
| Q4 2025 | 113 | 0 | 171.90M | $8.37B | n/a | n/a |
| Q3 2025 | 17 | 0 | 119.31M | $5.63B | +1 | −1 |
| Q2 2025 | 14 | -1 | 113.96M | $5.51B | n/a | −1 |
| Q1 2025 | 13 | -1 | 114.44M | $6.35B | +1 | −2 |
| Q4 2024 | 14 | 0 | 106.76M | $5.15B | n/a | n/a |
| Q3 2024 | 13 | 0 | 105.96M | $6.11B | +1 | −1 |
| Q2 2024 | 13 | n/a | 103.00M | $5.00B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | TD Waterhouse Canada Inc. | 215.37K | -1.9% | $8.76M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | Wealth Enhancement Advisory… | 63.42K | -38.0% | $2.55M | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 734 holders, 204.41M shares, $9.56B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.